{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-203149","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2024-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.362996+00:00","generated_at":"2026-05-31T08:25:02.635890+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Vaccinex calls warrants after positive Alzheimer's trial FDG-PET signal","bullets":["Warrants from Oct/Nov 2023, Feb/Mar 2024 financings called for cancellation at $0.0001/share.","Call triggered by statistically significant increase in FDG-PET signal in SIGNAL-AD pepinemab trial.","Warrant holders have 20 or 30 trading days to exercise; unexercised warrants auto-cancel.","Company plans to explore additional financing options, including warrant inducement or exchange.","No guarantee of warrant exercise or success of any potential financing transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-203149","json":"https://secwatch.observer/filing/0001193125-24-203149.json","markdown":"https://secwatch.observer/filing/0001193125-24-203149.md","text":"https://secwatch.observer/filing/0001193125-24-203149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524203149/0001193125-24-203149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312524203149/d867905d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:25:02.635890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}